State of Wyoming’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16,625
Closed -$254K 1807
2025
Q3
$254K Sell
16,625
-4,188
-20% -$54.5K 0.03% 783
2025
Q2
$184K Sell
20,813
-20,912
-50% -$184K 0.02% 978
2025
Q1
$327K Buy
41,725
+13,196
+46% +$111K 0.04% 496
2024
Q4
$300K Sell
28,529
-4,310
-13% -$52.3K 0.04% 565
2024
Q3
$431K Sell
32,839
-64
-0.2% -$975 0.06% 251
2024
Q2
$463K Sell
32,903
-8,364
-20% -$136K 0.08% 148
2024
Q1
$697K Sell
41,267
-7,437
-15% -$111K 0.12% 76
2023
Q4
$688K Buy
48,704
+6,903
+17% +$81.1K 0.13% 70
2023
Q3
$431K Buy
41,801
+6,842
+20% +$91.6K 0.09% 113
2023
Q2
$576K Buy
34,959
+8,056
+30% +$105K 0.17% 45
2023
Q1
$246K Sell
26,903
-2,207
-8% -$18.1K 0.08% 227
2022
Q4
$208K Buy
29,110
+4,001
+16% +$28.1K 0.07% 317
2022
Q3
$126K Buy
25,109
+12,006
+92% +$66.1K 0.06% 461
2022
Q2
$32K Buy
+13,103
New +$53.8K 0.02% 1219

Other funds holding AVDL

State of Wyoming's AVDL Position: Q4 2025 in Review

State of Wyoming sold out of Avadel Pharmaceuticals (AVDL) in Q4 2025, closing a stake of 16,625 shares — an estimated $254K sold.

State of Wyoming first reported a position in AVDL in Q2 2022 and held it in 14 quarters. The position peaked at $697K in Q1 2024. 207 funds tracked by Wall St. Rank hold AVDL as of Q4 2025.

  • State of Wyoming reported no remaining Avadel Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • State of Wyoming sold 16,625 Avadel Pharmaceuticals shares in Q4 2025, an estimated $254K.
  • State of Wyoming first reported a position in Avadel Pharmaceuticals in Q2 2022 and held it in 14 quarters.
  • State of Wyoming's Avadel Pharmaceuticals position peaked at $697K in Q1 2024.
  • 207 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2025.

Based on State of Wyoming's 13F filing for Q4 2025, filed 11 Feb 2026.